Health Medical
NUR 4667 Chamberlain College of Nursing Hepatitis C Disorder Questions

NUR 4667

Chamberlain College of Nursing

NUR

Question Description

I’m trying to learn for my Health & Medical class and I’m stuck. Can you help?

Hello please answer questions below no apa required but only in text citations.

1. The new direct acting anti-viral agents available to treat Hepatitis C hold the promise of cure for the vast majority of patients diagnosed with Hepatitis C. There are a number of potential barriers, however, to seeing this realized. While insurance coverage for these agent is improving, cost remains a significant barrier for many patients.

For your post, research avenues to help your patients overcome this barrier. Search for advocacy groups, patient assistance programs, and assistance offered directly from the pharmaceutical companies who make these drugs. Post a link to your classmates for a resource you found and summarize what is provided by this resource

2.Write up a brief summary of each type of hepatitis and one risk involved with each type of hepatitis and who it impacts. (a couple of lines nothing fancy),

3. Explore the CDC website regarding hepatitis and 500 words summary of the website. Include two facts that you found interesting regarding any type of hepatitis. Please note where you found your facts in your summary in text citation.



https://www.cdc.gov/hepatitis/resources/professionals/pdfs/abctable.pdf

Student has agreed that all tutoring, explanations, and answers provided by the tutor will be used to help in the learning process and in accordance with Studypool's honor code & terms of service.

Final Answer

Hello, I have made several changes to the paper, kindly utilize this upload, review, and get back in case of a concern.

1

Hepatitis Questions
Student’s Name
Institutional Affiliation

2
Hepatitis Questions
Hepatitis C is a viral disorder that inflames the liver, sometimes causing grievous liver
injury. Millman et al. (2017) presume that the "hepatitis C virus" (HCV) infection is a top cause
of hepatic-associated demise, hepatocellular carcinoma, and cirrhosis. The disorder is curable,
and patients normally receive antiviral formulations to lower the virus from the body with a goal
to achieve “sustained virologic response” at least twelve weeks after completion of the treatment.
Nevertheless, the formulations used are costly, and not all health insurance schemes cater for all
prescribed formulation for hepatitis C treatment, thereby posing a treatment barrier. According to
Millman et al. (2017), restrictive directions on access to new, curative, hepatitis C formulation
constitute a considerable challenge to managing infected persons.
Avenues to Help Patients Overcome Cost Barriers
Since curing HCV provides an enduring, substantial health advantage, including lowering
the number of cases of liver carcinoma (Tenner, Melhado, Bobadilla, Turner, & Morgan, 2019),
addressing the cost hurdles encountered by infected persons is imperative. Despite the high cost
of treatment, pharmaceutical firms have a “patient assistance program” (PAP) to aid uninsured
persons to cater for all or part of the costs of the medication. The article obtained in this
exploration is the “pharmaceutical company patient assistance and cost-sharing assistance
programs: hepatitis” (NASTAD, 2017). A PAP runs through pharmaceutical firms to give lowcost or free treatment to persons tha...

ephykam (9378)
University of Maryland

Anonymous
Thanks for the help.

Anonymous
Outstanding. Studypool always delivers quality work.

Anonymous
Tutor was very helpful and took the time to explain concepts to me. Very responsive, managed to get replies within the hour.

Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4
Similar Questions
Related Tags